CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 98 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $50,000 | -65.0% | 17,000 | -45.2% | 0.00% | -60.0% |
| Q2 2020 | $143,000 | +20.2% | 31,000 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $119,000 | +9.2% | 31,000 | +6.9% | 0.01% | +25.0% |
| Q4 2019 | $109,000 | -29.2% | 29,000 | 0.0% | 0.00% | -20.0% |
| Q3 2019 | $154,000 | +38.7% | 29,000 | 0.0% | 0.01% | +25.0% |
| Q2 2019 | $111,000 | -19.6% | 29,000 | +7.4% | 0.00% | -20.0% |
| Q1 2019 | $138,000 | +165.4% | 27,000 | 0.0% | 0.01% | +150.0% |
| Q4 2018 | $52,000 | -46.9% | 27,000 | +3.8% | 0.00% | -33.3% |
| Q3 2018 | $98,000 | +21.0% | 26,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $81,000 | +30.6% | 26,000 | 0.0% | 0.00% | +50.0% |
| Q1 2018 | $62,000 | -39.2% | 26,000 | 0.0% | 0.00% | -50.0% |
| Q4 2017 | $102,000 | +54.5% | 26,000 | 0.0% | 0.00% | +33.3% |
| Q3 2017 | $66,000 | -8.3% | 26,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $72,000 | – | 26,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $1,902,000 | 5.68% |
| GABLES CAPITAL MANAGEMENT INC. | 433,814 | $5,566,000 | 4.46% |
| Quantedge Capital Pte Ltd | 503,700 | $6,462,000 | 1.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,896,000 | $62,816,000 | 1.25% |
| Lanham O'Dell & Company, Inc. | 20,145 | $258,000 | 0.92% |
| Capital Impact Advisors, LLC | 59,301 | $907,000 | 0.90% |
| SummerHaven Investment Management, LLC | 98,840 | $1,268,000 | 0.88% |
| Yorktown Management & Research Co Inc | 50,000 | $642,000 | 0.83% |
| GLOBEFLEX CAPITAL L P | 304,293 | $3,904,000 | 0.67% |
| AFFINITY INVESTMENT ADVISORS, LLC | 90,864 | $1,166,000 | 0.60% |